About us

Deep industry expertise meets innovative thinking. SRI Empowers pharmaceutical leaders to navigate complexity, accelerate growth, and deliver meaningful patient impact.
Get in Touch

Our Story

Strategic Research Insights (SRI) is a Princeton, NJ based firm specializing in market research, data analytics, and strategic consulting for the life sciences industry. SRI is led by a seasoned leadership team with advanced academic credentials and over two decades of diverse experience in primary research and all types of secondary data analytics. We bring deep domain expertise and strategic vision to every client engagement across our three practice areas of Qualitative Research, Quantitative Research and Big Data Analytics (Rx, APLD Claims, EMR and Payor). Our offerings are state of the art incorporating appropriate AI and ML techniques.

As a top life sciences consulting firm, we maintain an unwavering commitment to providing precise, dependable insights that enable clients to make informed and high-impact strategic decisions.

Our Core Values

Never Say Never

At SRI, “Never say never” isn’t just a motto; it’s a mindset. We approach every challenge with bold creativity and a fearless, can-do spirit, always pushing beyond convention to uncover inventive, effective solutions.

Client Success First

We know the pressure our clients face. That’s why SRI is built around one promise: to make your job easier. We listen, adapt, and deliver with care, so you can focus on what matters most.

Enduring Trust

At SRI, every client engagement is a partnership. We work closely with the clients to craft the most effective, methodologically sound approach, tailored to their goals and built on trust.

Global Expertise

0+
Global markets
  • SRI routinely conducts research in partnership with trusted local experts across more than 50 global markets, and our reach continues to grow.
  • SRI has successfully led complex international research across countries, cultures, and stakeholder groups, delivering clarity and cohesion at every step.
  • Over half of SRI’s projects involve markets outside the U.S., reflecting our deep commitment to international research and cross-border collaboration.
The Americas
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Costa Rica
  • Ecuador
  • Mexico
  • Peru
  • United States
  • Venezuela
Australasia
  • Algeria​
  • Australia​
  • China
  • Hong Kong​
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines​
  • Saudi Arabia​
  • South Africa
  • South Korea​
  • Taiwan​
  • Thailand​
  • Turkey​​
  • UAE​
  • Vietnam​​
Europe
  • Austria​
  • Belgium​
  • Czech Republic​
  • Denmark​
  • Finland​
  • Lithuania​
  • Netherlands​
  • Norway​
  • Poland​
  • Portugal​
  • Russia​
  • Slovakia​
  • Slovenia​
  • Spain​
  • Sweden​
  • Switzerland​
  • United Kingdom​
  • France​
  • Germany​
  • Greece​
  • Hungary​
  • Italy​

SRI Strengths

SRI integrates pioneering methodologies, disciplined project execution, comprehensive end-to-end research capabilities, and deep therapeutic expertise to deliver strategic, high-impact insights.

Innovative Research and Technology

SRI is known for its innovations in market research, including proprietary AI algorithms for analyzing HCP audio responses, behavioral economics-based positioning exercises, and gamification techniques for respondent engagement.

Offerings and approaches such as TruEst™ demand estimation, AccuShare™ calibration, HabitRx™ behavioral models, DynaMO™ message optimization, and DocTalk™ audio analytics help clients achieve granular strategic insights.

The firm is an industry leader in GenAI integration into primary research projects, machine learning models, latent class segmentation, behavioral economics offerings, hierarchical Bayesian analytics, strategic simulators, blended max-diff models, and omnichannel Rx impact analysis, not to mention dozens of proprietary innovative offerings.

Project Management Excellence

Every project from SRI is managed by a team leader with senior-level expertise.

Direct access to principals ensures clients receive the benefit of experience and a consultative relationship across study design, sampling, questionnaire development, and final reporting.

SRI’s fieldwork excellence is proven by a consistent record of fulfilling all sample size commitments, recruiting 19,000 healthcare professionals (HCPs) and 13,000 patients/caregivers across hundreds of US and global studies in the past year alone.

Tight timeline surveys and global quantitative work are executed with high-quality recruitment and reliable results.

Market Research Lifecycle Support

SRI provides research and analytics at every stage, including:

Pre-launch planning, launch preparation, post-launch tracking, segmentation, brand positioning, message recall, sales force effectiveness, market event assessment, name/logo testing, creative testing, market structure analysis, patient journey mapping, forecasting, and demand estimation.

Therapeutic Experience

In-depth research experience in 60+ therapeutic areas, 20+ rare conditions, and 20+ oncology tumor types.

Experience working with difficult-to-reach respondents, including specialists and patients with low-incidence diseases.

Learn More

Our Promise

SRI guarantees excellence across the full engagement spectrum from deep qualitative insights and reliable quantitative data to cutting-edge big data analytics powered by AI and ML. Our consultative approach and value-added capabilities position SRI not just as a vendor, but as a strategic partner invested in each client's long-term success.

Our Mission

 Founders of SRI noted large scale departures of young graduates from consulting industry due to team dynamics in a highly demanding environment. To change status quo and differentiate SRI from other consulting firms, the Founders decided to devote a substantial amount of time to training young graduates and offer them a friendly, hierarchy-less environment for a successful career. The mission of SRI thus came to be:

To offer a non-political platform for younger graduates to work and contribute